Virpax Pharmaceuticals Inc. (NASDAQ: VRPX)
$0.6419
+0.0522 ( -20.51% ) 150.7M
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.
Market Data
Open
$0.6419
Previous close
$0.5897
Volume
150.7M
Market cap
$4.77M
Day range
$0.6210 - $1.1580
52 week range
$0.3625 - $5.5070
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| ars | Annual reports | 1 | Jun 12, 2024 |
| def | Proxies and info statements | 4 | Jun 12, 2024 |
| 8-k | 8K-related | 20 | May 17, 2024 |
| 10-q | Quarterly Reports | 54 | May 13, 2024 |
| 8-k | 8K-related | 14 | May 13, 2024 |
| 8-k | 8K-related | 14 | May 02, 2024 |
| 8-k | 8K-related | 15 | Apr 30, 2024 |
| 8-k | 8K-related | 13 | Apr 03, 2024 |
| 10-k | Annual reports | 76 | Mar 26, 2024 |
| 8-k | 8K-related | 15 | Mar 26, 2024 |